Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Gaurav Singh, Stanislav N Tolkachjov & Aaron S Farberg. (2023) Incorporation of the 40-Gene Expression Profile (40-GEP) Test to Improve Treatment Decisions in High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients: Case Series and Algorithm. Clinical, Cosmetic and Investigational Dermatology 16, pages 925-935.
Read now
Read now
Maki Yamamoto, Brenda Sickle-Santanello, Timothy Beard, Richard Essner, Brian Martin, Christine N. Bailey & J. Michael Guenther. (2023) The 31-gene expression profile test informs sentinel lymph node biopsy decisions in patients with cutaneous melanoma: results of a prospective, multicenter study. Current Medical Research and Opinion 39:3, pages 417-423.
Read now
Read now
Perry B. Hooper, Aaron S. Farberg, Alison L. Fitzgerald, Jennifer J. Siegel, Briana B. Rackley, Anesh Prasai, Sarah J. Kurley, Matthew S. Goldberg & Graham H. Litchman. (2022) Real-World Evidence Shows Clinicians Appropriately Use the Prognostic 40-Gene Expression Profile (40-GEP) Test for High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients. Cancer Investigation 40:10, pages 911-922.
Read now
Read now
Larry D. Dillon, Michael McPhee, Robert S. Davidson, Ann P. Quick, Brian Martin, Kyle R. Covington, Olga Zolochevska, Robert W. Cook, John T. Vetto, Abel D. Jarell & Martin D. Fleming. (2022) Expanded evidence that the 31-gene expression profile test provides clinical utility for melanoma management in a multicenter study. Current Medical Research and Opinion 38:8, pages 1267-1274.
Read now
Read now
Abel Jarell, Basil Skenderis, Larry D Dillon, Kelsey Dillon, Brian Martin, Ann P Quick, Jennifer J Siegel, Briana B Rackley & Robert W Cook. (2021) The 31-gene expression profile stratifies recurrence and metastasis risk in patients with cutaneous melanoma. Future Oncology 17:36, pages 5023-5031.
Read now
Read now
David M Hyams, Kyle R Covington, Clare E Johnson, Kristen M Plasseraud & Robert W Cook. (2021) Integrating the Melanoma 31-Gene Expression Profile Test with Surgical Oncology Practice Within National Guideline and Staging Recommendations. Future Oncology 17:5, pages 517-527.
Read now
Read now
Aaron S. Farberg, Mary A. Hall, Leah Douglas, Kyle R. Covington, Sarah J. Kurley, Robert W. Cook & Scott M. Dinehart. (2020) Integrating gene expression profiling into NCCN high-risk cutaneous squamous cell carcinoma management recommendations: impact on patient management. Current Medical Research and Opinion 36:8, pages 1301-1307.
Read now
Read now
Rebecca W Knackstedt, Thomas Knackstedt & Brian Gastman. (2019) Gene Expression Profiling in Melanoma: Past Results and Future Potential. Future Oncology 15:7, pages 791-800.
Read now
Read now
Morganna Freeman & Shachar Laks. (2019) Surveillance Imaging for Metastasis in High-Risk Melanoma: Importance in Individualized Patient Care and Survivorship. Melanoma Management 6:1.
Read now
Read now
John T. Vetto. (2019) Invited Brief Commentary: Sentinel Lymph Node Status is a Main Prognostic Parameter Needful for the Correct Staging of Patients with Melanoma Thicker than 4 mm: Single Institutional Experience and Literature Meta-analysis. Journal of Investigative Surgery 32:2, pages 162-163.
Read now
Read now
Omar Abdel-Rahman. (2018) Evaluation of the Eighth American Joint Committee on Cancer Staging System for Malignant Melanoma of the Skin. Future Oncology 14:5, pages 471-481.
Read now
Read now
Articles from other publishers (35)
Ashley Wysong, Ally‐Khan Somani, Sherrif F. Ibrahim, Javier Cañueto, Alison L. Fitzgerald, Jennifer J. Siegel, Anesh Prasai, Matthew S. Goldberg, Aaron S. Farberg, Christie Regula, Anna Bar, Julia Kasprzak, David G. Brodland, Shlomo A. Koyfman & Sarah T. Arron. (2024) Integrating the 40-Gene Expression Profile (40-GEP) Test Improves Metastatic Risk-Stratification Within Clinically Relevant Subgroups of High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients. Dermatology and Therapy 14:3, pages 593-612.
Crossref
Crossref
Tiffany W Cheng, Emily Hartsough & Alessio Giubellino. (2023) Sentinel lymph node assessment in melanoma: current state and future directions. Histopathology 83:5, pages 669-684.
Crossref
Crossref
Christine N. Bailey, Brian J. Martin, Valentina I. Petkov, Nicola C. Schussler, Jennifer L. Stevens, Suzanne Bentler, Rosemary D. Cress, Jennifer A. Doherty, Eric B. Durbin, Scarlett L. Gomez, Lou Gonsalves, Brenda Y. Hernandez, Lihua Liu, Bożena M. Morawski, Maria J. Schymura, Stephen M. Schwartz, Kevin C. Ward, Charles Wiggins, Xiao-Cheng Wu, Matthew S. Goldberg, Jennifer J. Siegel, Robert W. Cook, Kyle R. Covington & Sarah J. Kurley. (2023) 31-Gene Expression Profile Testing in Cutaneous Melanoma and Survival Outcomes in a Population-Based Analysis: A SEER Collaboration. JCO Precision Oncology:7.
Crossref
Crossref
Bo M. Kitrell, Elliot D. Blue, Alfredo SillerJr.Jr., Marissa B. Lobl, Tyler D. Evans, Melodi Javid Whitley & Ashley Wysong. (2023) Gene Expression Profiles in Cutaneous Oncology. Dermatologic Clinics 41:1, pages 89-99.
Crossref
Crossref
Kelli Ahmed, Jennifer J. Siegel, Sonia K. Morgan‐Linnell & Kyleigh LiPira. (2022) Attitudes of patients with cutaneous melanoma toward prognostic testing using the 31‐gene expression profile test. Cancer Medicine 12:2, pages 2008-2015.
Crossref
Crossref
Abel Jarell, Brian R. Gastman, Larry D. Dillon, Eddy C. Hsueh, Sebastian Podlipnik, Kyle R. Covington, Robert W. Cook, Christine N. Bailey, Ann P. Quick, Brian J. Martin, Sarah J. Kurley, Matthew S. Goldberg & Susana Puig. (2022) Optimizing treatment approaches for patients with cutaneous melanoma by integrating clinical and pathologic features with the 31-gene expression profile test. Journal of the American Academy of Dermatology 87:6, pages 1312-1320.
Crossref
Crossref
Aaron S. Farberg, Justin W. Marson, Alex Glazer, Graham H. Litchman, Ryan Svoboda, Richard R. Winkelmann, Nicholas Brownstone & Darrell S. Rigel. (2022) Expert Consensus on the Use of Prognostic Gene Expression Profiling Tests for the Management of Cutaneous Melanoma: Consensus from the Skin Cancer Prevention Working Group. Dermatology and Therapy 12:4, pages 807-823.
Crossref
Crossref
Aaron S. Farberg, Alison L. Fitzgerald, Sherrif F. Ibrahim, Stan N. Tolkachjov, Teo Soleymani, Leah M. Douglas, Sarah J. Kurley & Sarah T. Arron. (2022) Current Methods and Caveats to Risk Factor Assessment in Cutaneous Squamous Cell Carcinoma (cSCC): A Narrative Review. Dermatology and Therapy 12:2, pages 267-284.
Crossref
Crossref
Maribel L. Da Cunha Cosme, Juan F. Liuzzi Samaterra, Saul A. Siso Cardenas & José I. Chaviano Hernández. (2021) Lymphadenectomy after a positive sentinel node biopsy in patients with cutaneous melanoma. A systematic review. Surgical and Experimental Pathology 4:1.
Crossref
Crossref
Aaron W. Kangas-Dick, Alissa Greenbaum, Victor Gall, Roman Groisberg, Janice Mehnert, Chunxia Chen, Dirk F. Moore, Adam C. Berger & Vadim Koshenkov. (2021) Evaluation of a Gene Expression Profiling Assay in Primary Cutaneous Melanoma. Annals of Surgical Oncology 28:8, pages 4582-4589.
Crossref
Crossref
Sebastian PODLIPNIK, Miriam POTRONY & Susana PUIG. (2021) Genetic markers for characterization and prediction of prognosis of melanoma subtypes: a 2021 update. Italian Journal of Dermatology and Venereology 156:3.
Crossref
Crossref
Xubin Dong, Jingjing Song, Buran Chen, Yufeng Qi, Wenjie Jiang, Huihui Li, Danni Zheng, Yinghao Wang, Xiaohua Zhang & Haiguang Liu. (2021) Exploration of the Prognostic and Immunotherapeutic Value of B and T Lymphocyte Attenuator in Skin Cutaneous Melanoma. Frontiers in Oncology 10.
Crossref
Crossref
Ashley Wysong, Jason G. Newman, Kyle R. Covington, Sarah J. Kurley, Sherrif F. Ibrahim, Aaron S. Farberg, Anna Bar, Nathan J. Cleaver, Ally-Khan Somani, David Panther, David G. Brodland, John Zitelli, Jennifer Toyohara, Ian A. Maher, Yang Xia, Kristin Bibee, Robert Griego, Darrell S. Rigel, Kristen Meldi Plasseraud, Sarah Estrada, Lauren Meldi Sholl, Clare Johnson, Robert W. Cook, Chrysalyne D. Schmults & Sarah T. Arron. (2021) Validation of a 40-gene expression profile test to predict metastatic risk in localized high-risk cutaneous squamous cell carcinoma. Journal of the American Academy of Dermatology 84:2, pages 361-369.
Crossref
Crossref
Sachchida Nand Pandey. 2021. Skin Cancer: Pathogenesis and Diagnosis. Skin Cancer: Pathogenesis and Diagnosis
101
130
.
Bradley N. Greenhaw, Kyle R. Covington, Sarah J. Kurley, Yildiray Yeniay, Nhat Anh Cao, Kristen M. Plasseraud, Robert W. Cook, Eddy C. Hsueh, Brian R. Gastman & Maria L. Wei. (2020) Molecular risk prediction in cutaneous melanoma: A meta-analysis of the 31-gene expression profile prognostic test in 1,479 patients. Journal of the American Academy of Dermatology 83:3, pages 745-753.
Crossref
Crossref
Kevin Yang, Allen S.W. Oak, Radomir M. Slominski, Anna A. Brożyna & Andrzej T. Slominski. (2020) Current Molecular Markers of Melanoma and Treatment Targets. International Journal of Molecular Sciences 21:10, pages 3535.
Crossref
Crossref
Rogeh Habashi & Valerie Francescutti. (2020) Nonsurgical Management of Lymph Node Basins in Melanoma. Surgical Clinics of North America 100:1, pages 91-107.
Crossref
Crossref
George Jour. (2020) DecisionDx‐Melanoma and Sentinel Lymph Node Biopsy: To Do or Not to Do?. Dermatologic Surgery 46:1, pages 131-131.
Crossref
Crossref
Danielle P. Dubin, Scott M. Dinehart & Aaron S. Farberg. (2019) Level of Evidence Review for a Gene Expression Profile Test for Cutaneous Melanoma. American Journal of Clinical Dermatology 20:6, pages 763-770.
Crossref
Crossref
S. Podlipnik, C. Carrera, A. Boada, N.A. Richarz, J.L. López‐Estebaranz, F. Pinedo‐Moraleda, M. Elosua‐González, M.M. Martín‐González, R. Carrillo‐Gijón, P. Redondo, E. Moreno, J. Malvehy & S. Puig. (2019)
Early outcome of a 31‐gene expression profile test in 86
AJCC
stage
IB
‐
II
melanoma patients. A prospective multicentre cohort study
. Journal of the European Academy of Dermatology and Venereology 33:5, pages 857-862.
Crossref
Crossref
Jennifer Keller, Theresa L. Schwartz, Jason M. Lizalek, Ea‐sle Chang, Ashaki D. Patel, Maria Y. Hurley & Eddy C. Hsueh. (2019) Prospective validation of the prognostic 31‐gene expression profiling test in primary cutaneous melanoma. Cancer Medicine 8:5, pages 2205-2212.
Crossref
Crossref
Giselle Prado, Ryan M. Svoboda & Darrell S. Rigel. (2019) What's New in Melanoma. Dermatologic Clinics 37:2, pages 159-168.
Crossref
Crossref
Brian R. Gastman, Pedram Gerami, Sarah J. Kurley, Robert W. Cook, Sancy Leachman & John T. Vetto. (2019) Identification of patients at risk of metastasis using a prognostic 31-gene expression profile in subpopulations of melanoma patients with favorable outcomes by standard criteria. Journal of the American Academy of Dermatology 80:1, pages 149-157.e4.
Crossref
Crossref
Elisabeth Hamelin Tracey & Alok Vij. (2019) Updates in Melanoma. Dermatologic Clinics 37:1, pages 73-82.
Crossref
Crossref
Jacquelyn Reuther, Angshumoy Roy & Federico A. Monzon. 2019. Genomic Applications in Pathology. Genomic Applications in Pathology
33
49
.
David M. Hyams, Robert W. Cook & Antonio C. Buzaid. (2018) Identification of risk in cutaneous melanoma patients: Prognostic and predictive markers. Journal of Surgical Oncology 119:2, pages 175-186.
Crossref
Crossref
Robert W. Cook, Brooke Middlebrook, Jeff Wilkinson, Kyle R. Covington, Kristen Oelschlager, Federico A. Monzon & John F. Stone. (2018) Analytic validity of DecisionDx-Melanoma, a gene expression profile test for determining metastatic risk in melanoma patients. Diagnostic Pathology 13:1.
Crossref
Crossref
Luisa Christensen, Jeffrey Scott & Jeremy Bordeaux. (2018) Use of gene expression profile testing as a prognostic tool in early-stage cutaneous melanoma – compelling but not ready for primetime. Melanoma Research 28:6, pages 652-654.
Crossref
Crossref
Charles J. Puza, Andrew S. Barbas & Paul J. Mosca. (2018) Outcomes of patients with a pretransplant history of early-stage melanoma. Melanoma Research 28:5, pages 471-474.
Crossref
Crossref
Dirk Schadendorf, Alexander C J van Akkooi, Carola Berking, Klaus G Griewank, Ralf Gutzmer, Axel Hauschild, Andreas Stang, Alexander Roesch & Selma Ugurel. (2018) Melanoma. The Lancet 392:10151, pages 971-984.
Crossref
Crossref
Gerald Saldanha, Jeremy Yarrow, Jay Pancholi, Katarina Flatman, Kah Wee Teo, Somaia Elsheik, Rebecca Harrison, Marie O’Riordan & Mark Bamford. (2018) Breslow Density Is a Novel Prognostic Feature That Adds Value to Melanoma Staging. American Journal of Surgical Pathology 42:6, pages 715-725.
Crossref
Crossref
Bachar Hamade, Bradley Barnett, Trent R. Malcolm & Matthew J. Levy. (2017) Young Woman With Eye Pressure. Annals of Emergency Medicine 70:6, pages e53-e54.
Crossref
Crossref
Philip Friedlander. (2017) Advances in the Management of Melanoma. Current Dermatology Reports 6:4, pages 288-296.
Crossref
Crossref
Aaron S. Farberg, Alex M. Glazer, Richard R. Winkelmann & Darrell S. Rigel. (2017) Assessing Genetic Expression Profiles in Melanoma Prognosis. Dermatologic Clinics 35:4, pages 545-550.
Crossref
Crossref
Laura K. Ferris, Aaron S. Farberg, Brooke Middlebrook, Clare E. Johnson, Natalie Lassen, Kristen M. Oelschlager, Derek J. Maetzold, Robert W. Cook, Darrell S. Rigel & Pedram Gerami. (2017) Identification of high-risk cutaneous melanoma tumors is improved when combining the online American Joint Committee on Cancer Individualized Melanoma Patient Outcome Prediction Tool with a 31-gene expression profile–based classification. Journal of the American Academy of Dermatology 76:5, pages 818-825.e3.
Crossref
Crossref